An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are...

The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...

A new study, which is to be presented to the RNID Hearing Therapeutics Summit, found that a drug called Pedmark, also known as ...

For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain...

In a landmark study of 125 Australian children with high-risk cancer—whose tumor cells were grown in the lab and tested against a suite...

In early studies, the targeted chemotherapy drug has shown to annihilate tumours without affecting surrounding healthy cells. Read more:...

BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...

Published this week in Science Translational Medicine, the research paves the way to safer and more effective treatment options for ...

In a new report in Science Advances, Sara G. Danielli and an international, interdisciplinary team of scientists at the department of ...

Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...